Down-regulation of intrahepatic CD16+ and CD56+ immune cells in chronic Hepatitis C virus infection and HCV-related hepatocellular carcinoma

Archives of Medical Science

Volumn 5, Issue 3, 2009, Pages 321-328

  El Bassiouny, Azza ^a   El Hassan, Samah Abo ^b   Moussa, Mona ^c   El Ahwany, Eman ^a   Helal, Eman ^d   Taha, Alaa ^b   Helmy, Ahmed Hazem ^b   Kamel, Manal ^a   El Bassiouni, Nora ^c  

^a Giza   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c Imbaba   (Egypt)

^d Assiut Branch   (Egypt)

Author keywords

CD16; CD56; Chronic hepatitis C; Hepatitis C virus; Hepatocellular carcinoma; Liver cirrhosis C; Natural killer

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL;

EID: 73449133722     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. El-Zayadi AR, Abaza HF, Shawky S, et al. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt: A single centre experience. Hepatol Res 2001; 19: 170-9.
2. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285: 26-30.
3. Seow T, Liang R, Leow C. Hepatocellular carcinoma: From beside to proteomics. Review 2006; 1: 21-35.
4. El-Zayadi AR, Badran HM, Barakat EM, et al. Hepatocellular carcinoma in Egypt: A single center study over a decade. World J Gastroenterol 2005; 33: 5193-8.
5. Kawarabayashi N, Seki S, Hatsuse K, et al. Decrease of CD56+ T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000; 32: 962-9.
6. Li Y, Zhang T, HO C, et al. Natural killer cells inhibit hepatitis C virus expression. J Leukeo Biol 2004; 76: 1171-9.
7. Dowdell KC, Cua DJ, Kirkman E, et al. NK cells regulate CD4 responses prior to antigen encounter. J Immunol 2003; 171: 234-9.
8. Mizukoshi E, Rehermann B. Immune responses and immunity in hepatitis C virus infection. Gastroenterology 2001; 36: 799-808.
9. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191: 1499-512.
10. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
11. French AR, Yokoyama WM. Natural killer cells and viral infections. Curr Opin Immunol 2003; 15: 45-51.
12. Gilfillan S, Ho EL, Cella M, et al. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 2002; 3: 1150-5.
13. Ahmad A, Menezes J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J 1996; 10: 258-66.
14. Sherif S, Todd A, Ruggeri L, et al. Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 1935-47.
15. Mavilio D, Benjamin J, Kim D, et al. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 2005; 106: 1718-25.
16. Golden-Mason L, Castelblanco N, O'Farrelly C, Rosen H. Phenotypic and functional changes of cytotoxic CD56+ natural T cells determine outcome of acute hepatitis C virus infection. J Virol 2007; 81: 9292-8.
17. Saber MA, Omar M, Badawi H, et al. Comparative studies in serological diagnosis of hepatitis C virus infection. J Hep Gast Inf Dis 1995; 3: 47-51.
18. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatol 1994; 20: 15-20.
19. Ishak KG. Virus interference: The interferon. Proc R Soc Lond B Biol Sci 1994; 147: 258-67.
20. Hsu SM, Raine L, Fanger A. A comparative study of the peroxidase-anti-peroxidase method and avidin-biotin complex method for studying polypeptide hormones with radio-immunoassay antibodies. Am J Clin Path 1981; 75: 734-5.
21. Racanelli V, Rehermann B. Hepatitis C virus infection: When silence is deception. Trends Immunol 2003; 24: 456-64.
22. Deignan T, Curry MP, Doherty DG, et al. Decrease in hepatic CD 56+ T cells and Valpha24+ natural killer T cells in chronic hepatitis C viral infection. J Hepatol 2002; 37: 101-8.
23. Yonekura K, Ichida T, Sato K, et al. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver 2000; 20: 357-65.
24. Biron CA, Dalod M, Salazar-Mather TP. Innate immunity and viral infection. In: Immunology of Infectious Diseases. Kaufmann SH, Sher A, Ahmed R (eds), Washington DC, ASM Press 2002; 139-60.
25. Cooper MA, Fehniger TA, Caligiuri MA. Biology of human natural killer cell subsets. Trends Immunol 2001; 22: 633-40.
26. Lin AW, Gonzalez SA, Cunningham-Rundles S, et al. CD56+dim and CD56+bright cell activation and apoptosis in hepatitis C virus infection. Clin Exp Immunol 2004; 137: 408-16.
27. Kakimi K, Guidotti LG, Koezuka Y, et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192: 921-30.
28. Slifka MK, Pagerigen RR, Whitton JL. NK markers are expressed at a high percentage on virus-specific CD8+ and CD4+ T cells. J Immunol 2000; 164: 2009-15.
29. Panasiuk A, Prokopowicz D, Zak J, et al. Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C. Hepatogastroenterol 2003; 50: 178-82.
30. Diefenbach A, Jamieson AM, Liu SD, et al. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1: 119-25.
31. Ahmad A, Alvarez F. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J Leukeo Biol 2004; 76: 743-59.
32. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174: 5-20.
33. Cai L, Zhang Z, Zhou L, et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 2008; 129: 428-37.
34. Jinushi M, Takehara T, Kanto T, et al. Critical role of MHC class 1-related chain A and B expression on IFN-alpha-stimulated dendritic cells in natural killer cell activation: Impairment in chronic hepatitis C virus infection. J Immunol 2003; 170: 1249-56.